Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment

<div>Survival rate analysis of the tolerance-inducing effect of LTA pretreatment based on the Kaplan-Meier method. (a) C57BL/6J mice treated with CpG/D-galN. (b) C57BL/6J mice treated with R848/D-galN. (c) C3H mice treated with R848/D-galN.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment 

Figure 2 | Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment 